The Khavinsky Longevity Protocol: Epithalon, Thymalin, and Pinealon
Professor Vladimir Khavinsky and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology have produced over four decades of research on short peptide bioregulators — compounds designed to restore and normalize the function of specific organs and systems as they age. The core longevity protocol combines three bioregulators: Epithalon for pineal gland and telomere function, Thymalin for immune system restoration, and Pinealon for brain cortex neuroprotection.
What are bioregulator peptides?
Bioregulator peptides are a class of extremely short peptides — typically 2–4 amino acids — that work by penetrating cell nuclei and directly influencing gene expression. Unlike pharmaceutical drugs that block or activate specific receptor pathways, bioregulators are understood to work epigenetically, modulating the transcription of genes associated with the function of specific target organs. The Khavinsky group's theoretical framework is that aging involves a progressive dysregulation of gene expression in key regulatory organs — particularly the pineal gland, thymus, and brain cortex — and that organ-specific short peptides can partially restore this regulation.
The research program spans over 40 years, multiple longitudinal human studies, and thousands of animal model experiments. The compounds have been approved as pharmaceutical agents in Russia and several Eastern European countries. Western clinical adoption has been limited, but researcher interest has grown significantly in the longevity and biohacking communities since 2020.
Epithalon: telomere maintenance and pineal restoration
Epithalon (also spelled epitalon, chemical sequence Ala-Glu-Asp-Gly) is a synthetic tetrapeptide derived from epithalamin, a natural polypeptide extracted from bovine pineal gland tissue. It is one of only a small number of compounds in the research literature that has demonstrated telomerase activation — the enzyme responsible for maintaining and extending the protective telomere caps at the ends of DNA strands. Telomeres shorten with each cell division; critically shortened telomeres trigger cellular senescence and are a primary hallmark of biological aging.
In studies from the Khavinsky group and collaborating institutions, Epithalon demonstrated: telomerase activation and telomere elongation in somatic cells in vitro; significant lifespan extension in animal models with reduced tumor incidence; restoration of melatonin secretion in aged animals through normalization of pineal gland function; and antioxidant activity reducing oxidative damage markers. A 6-year longitudinal human study in elderly patients showed reduced mortality rates and improved biological age markers in Epithalon-treated groups versus controls.
Research protocol: 10mg daily subcutaneous injection for 20 consecutive days, 2–3 times per year. Available in 10mg and 50mg vials. See the Epithalon research profile.
Thymalin: immune system restoration
Thymalin is a natural peptide bioregulator extracted from bovine thymus gland. The thymus is the primary organ responsible for T-cell maturation and immune education — but it undergoes progressive involution (shrinkage) beginning in early adulthood, shrinking to a fraction of its original size by age 50–60. This thymic involution is directly responsible for the decline in adaptive immune function associated with aging: fewer naive T-cells are produced, the T-cell repertoire becomes less diverse, and both cellular and humoral immunity weaken.
Thymalin's mechanism operates by restoring thymus function at the cellular level: it normalizes T-lymphocyte activity, corrects the ratio between T-helper and T-suppressor cells, and stimulates both cellular and humoral immune responses. In Khavinsky's longitudinal research with elderly participants over a 6-year follow-up, Thymalin-treated groups showed significantly reduced mortality rates, improved immune markers, and better functional health outcomes versus controls. The key distinction in the Khavinsky protocol is between Thymalin (used cyclically for long-term immune system restoration) and Thymosin Alpha-1 / TA-1 (used acutely when sick for immediate immune activation). They serve different functions and can be used complementarily.
Research protocol: 5–10mg subcutaneous or intramuscular daily for 10 consecutive days, 2–3 times per year. Typically run concurrently with Epithalon cycles for the complete Khavinsky protocol. See the Thymalin research profile.
Pinealon: brain cortex neuroprotection
Pinealon (the EDR peptide, sequence Glu-Asp-Arg) is a synthetic tripeptide developed by the Khavinsky group as a brain cortex bioregulator. With a molecular weight of 418.4 g/mol, it is small enough to cross the blood-brain barrier via the PEPT2 transporter system — a capability that most larger peptides lack. Its primary mechanism is epigenetic gene regulation: Pinealon directly influences the expression of genes involved in neurogenesis, memory formation, and circadian rhythm by entering cell nuclei and modulating transcription factor activity.
Research findings include: increased irisin levels (a peptide linked to neuron proliferation and differentiation); antioxidant neuroprotection against oxidative and excitotoxic damage; and in a clinical rehabilitation study, 59.4% of traumatic brain injury patients showed measurable memory improvement when Pinealon was added to standard rehabilitation protocols. Pinealon is one of the active compounds in Cortexin, a multi-peptide therapeutic used clinically for TBI treatment in Russia and several other countries.
Research protocol: 10–20mg oral tablets daily for 20–30 consecutive days, 2–3 times per year. Pairs with Epithalon for the complete Khavinsky protocol. Also used in the Calm and Clarity blend with PE-22-28 and Selank. See the Pinealon research profile.
Combining the three bioregulators
The full Khavinsky longevity protocol runs Epithalon and Thymalin concurrently (both are injectable and share the same 10-day intensive cycle format) and adds Pinealon orally throughout. The combination targets three distinct systems simultaneously: the pineal gland and telomere biology (Epithalon), the thymic immune architecture (Thymalin), and the brain cortex neuroprotective system (Pinealon). The three organs targeted — pineal gland, thymus, and brain cortex — are each primary regulators of systemic aging through different pathways, which is why the combined protocol is more comprehensive than any single bioregulator alone.
Research references
- Khavinson VKh, et al. (2003). Epitalon peptide induces telomerase activity — PubMed
- Anisimov VN, et al. (2004). Effect of Epitalon on biomarkers of aging — PubMed
Research sourcing: For research-grade Epithalon and Thymalin with third-party COA documentation, Peptide Hub recommends Amino Club (partner code: PEPTIDEHUB). Affiliate link — we earn a commission at no cost to you.